Immune Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Immune Pharmaceuticals: Two For The Price Of One
Article By: Kayla Schiffer
Monday, July 17, 2017 12:15 PM EDT
Immune Pharmaceuticals is gearing up for its split into two pure play companies with new patent filings, strategic deals for commercialization, and the initiation of new clinical trials to support its wide-ranging pipeline.
In this article: IMNP Also: PFE, SNY, ANAC, REGN, MYL
Read
Immune Pharma To Unlock Value And Create Two Separate Pure Play Companies; Cytovia, Immune
Article By: Ari Zoldan
Tuesday, July 11, 2017 3:13 PM EDT
Immune expects that the focus of Cytovia will be the European market for the drug, which has an addressable market of $175 million, while Pint will focus on the Latin America market with an addressable market of $100 million.
In this article: IMNP Also: MYL, BMY, MRK, SNY, TYO, GSK, ARIA, NVS
Read
Who Are The Next Acquisition Targets In Dermatology?
Article By: Ari Zoldan
Wednesday, March 22, 2017 8:25 AM EDT
Specialty pharmaceuticals is a highly dynamic sector with robust stock valuations and an active mergers & acquisition market. One of the most attractive areas for investment is dermatology.
In this article: IMNP, AZN, PFE, SNY, ANAC, RGEN, DERM, FOMX, LBTSF
Read
Immune Pharmaceuticals Is Really Trying Hard
Article By: Jason Napodano
Tuesday, January 17, 2017 2:53 PM EDT
It’s hard to imagine a 21¢ stock with more going on than Immune Pharmaceuticals. The company is really trying in my opinion. There have clearly been past struggles, but I have no issues with the current strategy.
In this article: IMNP
Read
3 Small Caps Under $5 With Heavy Insider Buying
Article By: Bret Jensen
Tuesday, September 22, 2015 7:41 PM EDT
With the advent and explosion of online financial content it is easier than ever to be aware of what insiders are buying and selling at their companies. Here are three small caps stocks that look attractive and also have had recent insider buying.
In this article: LTS, PTX, IMNP Also: RJF
Read
All Posts

Latest Tweets for $IMNP

No tweets yet!

PARTNER HEADLINES

$IMNP

Comments Status Updates
Immune Pharma To Unlock Value And Create Two Separate Pure Play Companies; Cytovia, Immune
Craig Newman • 7/13/2017 3:32:02 AM

Only time will tell if this is good for $IMNP.

Who Are The Next Acquisition Targets In Dermatology?
Alpha Stockman • 3/22/2017 8:22:08 PM

I've had my eye on $IMNP lately but it's hard to find coverage on this stock.

1 to 2 of 2 comments